Skip to main content
logo
Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
14.19
-1.11 (-7.25%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Contineum Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
534418378---
Market Cap Growth
173.92%10.56%----
Enterprise Value
304241164---
Last Close Price
14.1911.4314.65---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.231.601.91---
P/TBV Ratio
2.231.601.91---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.030.030.010.150.08
Debt / EBITDA Ratio
---0.03--
Debt / FCF Ratio
---0.03--
Net Debt / Equity Ratio
-0.96-0.98-1.00-1.00-1.05-1.04
Net Debt / EBITDA Ratio
3.493.763.92-7.661.852.26
Net Debt / FCF Ratio
4.304.595.95-6.582.052.42
Asset Turnover
---0.55--
Quick Ratio
36.2526.9820.5322.836.2618.78
Current Ratio
37.1727.5020.6923.296.4118.99
Return on Equity (ROE)
-28.01%-26.13%-26.19%27.71%-48.09%-
Return on Assets (ROA)
-19.15%-17.38%-18.54%11.10%-23.44%-
Return on Invested Capital (ROIC)
-652.37%-2303.96%----
Return on Capital Employed (ROCE)
-27.20%-25.50%-25.10%12.90%-52.70%-42.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.78%-14.37%-11.19%---
FCF Yield
-10.01%-13.30%-8.83%---
Buyback Yield / Dilution
-29.38%-43.14%-469.95%-51.38%-6.35%-
SEC Filings: 10-K · 10-Q